Aarti Pharmalabs Limited — Board Meeting, 12-08-2025: Outcome of Board Meeting

Aarti Pharmalabs' board approved consolidated financial results for the quarter ended June 30, 2025, reporting revenue of ₹38.62 Cr and a net profit of ₹4.95 Cr. Basic EPS reached ₹5.46. Key decisions include the proposed appointment of M/s Mehta and Mehta as Secretarial Auditors for five years, pending shareholder approval. The board also cleared the re-appointment of Ms. Rupal Vora as an Independent Director for a second three-year term, subject to AGM nod. Additionally, the company expanded its Stock Option Scheme to include eligible employees and directors of its subsidiaries, requiring shareholder consent.